197A — TAUNS Laboratories Cashflow Statement
0.000.00%
- ¥58bn
- ¥64bn
- ¥19bn
- 69
- 48
- 66
- 68
Annual cashflow statement for TAUNS Laboratories, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Yuho | Tanshin |
Standards: | JAS | JAS | JAS | — |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | 7,976 | 4,655 | 7,835 | 8,202 |
Depreciation | ||||
Non-Cash Items | 3,363 | 327 | 399 | -212 |
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 773 | -8,779 | 1,025 | -1,887 |
Change in Accounts Receivable | ||||
Change in Inventories | ||||
Change in Accounts Payable | ||||
Change in Taxes Payable | ||||
Change in Other Liabilities | ||||
Other Operating Cash Flow | ||||
Cash from Operating Activities | 12,679 | -3,158 | 9,935 | 6,818 |
Capital Expenditures | -2,300 | -1,166 | -3,961 | -5,121 |
Purchase of Fixed Assets | ||||
Purchase / Acquisition of Intangibles | ||||
Other Investing Cash Flow Items | -380 | -450 | -149 | -4,137 |
Sale of Fixed Assets | ||||
Purchase of Investments | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | -2,680 | -1,615 | -4,110 | -9,258 |
Financing Cash Flow Items | -1,800 | -1,900 | -16.5 | -0.001 |
Other Financing Cash Flow | ||||
Total Cash Dividends Paid | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | -3,660 | -330 | 2,356 | 2,281 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 6,339 | -5,103 | 8,181 | -158 |